Health News

In a study published online this week in the leading cancer journal, Journal of Clinical Oncology, Westchester Medical Center Physician Dr. Kutluk Oktay, MD, Director, Division of Reproductive Medicine & Infertility concluded that mutations in the BRCA1 gene (gene associated with early onset breast cancer) are associated with early diminishment of egg reserve…

Read more

Filed under: Women's Health
Tags: cancer, gene, medicine, Oncology, Online, Women's Health

Related posts

• When To Administer Food And Drugs Together (0)
  A regulatory bias against taking oral anti-cancer medications with food places many patients at increased risk for an overdose and forces them to "flush costly medicines down the toilet," argues Mark Ratain, MD, an authority on cancer-drug dosing. In a commentary published early online Sept. 19 in the Journal of Clinical Oncology, Ratain, the Leon [...]
  
  
• Weakened RNA Interference Reduces Survival In Ovarian Cancer (0)
  Levels of two proteins in a woman's ovarian cancer are strongly associated with her likelihood of survival, a research team led by scientists at The University of Texas M. D. Anderson Cancer Center reports in the Dec. 18 issue of the New England Journal of Medicine. The study shows that women with [...]
  
  
• Study Of Placenta Unexpectedly Leads To Cancer Gene (0)
  University of Rochester Medical Center scientists discovered a gene mutation that impairs the placenta and also is influential in cancer development, according to a study published online December 16, 2008, in the journal PLoS (Public Library of Science) Biology. The investigation is the first to link the key placental gene, SENP2, to [...]
  
  
• Study Confirms Long-Lasting Benefit Of Trastuzumab (Herceptin) For Women With Early-Stage Breast Cancer (0)
  Women with an aggressive type of early-stage breast cancer (HER2-positive disease) given trastuzumab (Herceptin) for one year following standard chemotherapy are at significantly less risk of the cancer returning, and the effect is long lasting, according to the long-term results of the landmark HERA trial published Online First in The Lancet Oncology... Read more [tags] Women's Health [...]
  
  
• Study Confirms Long-Lasting Benefit Of Trastuzumab (Herceptin) For Women With Early-Stage Breast Cancer (0)
  Women with an aggressive type of early-stage breast cancer (HER2-positive disease) given trastuzumab (Herceptin) for one year following standard chemotherapy are at significantly less risk of the cancer returning, and the effect is long lasting, according to the long-term results of the landmark HERA trial published Online First in The Lancet Oncology... Read more [tags] Women's Health [...]